MedTrace Logo

Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation

NCT01203202 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2012-10-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether PED-1 (15mg) and PED-2 (30mg) are tolerable and effective in the treatment of premature ejaculation.

Conditions

  • Premature Ejaculation

Interventions

DRUG

Clomipramine

15mg and 30mg on demand

Sponsors & Collaborators

  • Symyoo

    lead INDUSTRY

Principal Investigators

  • Whan-Seok Choi, MD, PhD · Seoul St. Marry's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01203202 on ClinicalTrials.gov